|
|
Office Locations:
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Mid Atlantic Bio Angels group (MABA) is an angel investor group focused exclusively on new and emerging life science companies. Membership in MABA is by invitation only, and is extended to active, accredited investors (life science angels) who wish to make investments in life science companies, as well as institutional investors and life science company venture arms wishing to invest alongside the angels. MABA places no geographical restrictions or requirements for presenting companies and invests primarily in pharmaceuticals, health devices, and health apps. Entrepreneurs can apply to pitch to MABA, and some of the 60 members may invest together to create a funding round of up to $500,000. MABA is not a fund and its members invest as individuals or as a group -- at their discretion, or as arranged with the company receiving the investment. The Steering Committee (SC) consists of approximately 12-15 individuals who are already members and who devote additional time to shaping the vision of the organization, as well as the process of selecting and (to a limited extent) coaching of presentation candidates.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
